Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Scholz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|April 16, 1998
Active drug substance impurity profiling part I. LC/UV diode array spectral matchingE C Nicolas, T H Scholz
Journal of Pharmaceutical and Biomedical Analysis|April 16, 1998
Active drug substance impurity profiling part II. LC/MS/MS fingerprintingE C Nicolas, T H Scholz
Journal of Pharmaceutical and Biomedical Analysis|March 29, 2001
Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777D Buckley, M J Haas, T H Scholz, et al.
Pharmaceutical Research|December 1, 1996
Degradation kinetics of DMP 777, an elastase inhibitorK S Raghavan, D B Gray, T H Scholz, et al.
Journal of Medicinal Chemistry|July 23, 1993
Sulfonylmethanesulfonamide inhibitors of carbonic anhydraseT H Scholz, J M Sondey, W C Randall, et al.
Journal of Medicinal Chemistry|February 1, 1990
Topically active carbonic anhydrase inhibitors. 3. Benzofuran- and indole-2-sulfonamidesS L Graham, J M Hoffman, P Gautheron, et al.
Journal of Medicinal Chemistry|September 29, 1995
Pseudodipeptide inhibitors of protein farnesyltransferaseS J deSolms, A A Deana, E A Giuliani, et al.
Journal of Medicinal Chemistry|October 1, 1991
Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamidesK L Shepard, S L Graham, R J Hudcosky, et al.
Journal of Medicinal Chemistry|July 3, 1998
N-Arylalkyl pseudopeptide inhibitors of farnesyltransferaseS J deSolms, E A Giuliani, S L Graham, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|April 16, 1998
Active drug substance impurity profiling part I. LC/UV diode array spectral matchingE C Nicolas, T H Scholz
Journal of Pharmaceutical and Biomedical Analysis|April 16, 1998
Active drug substance impurity profiling part II. LC/MS/MS fingerprintingE C Nicolas, T H Scholz
Journal of Pharmaceutical and Biomedical Analysis|March 29, 2001
Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777D Buckley, M J Haas, T H Scholz, et al.
Pharmaceutical Research|December 1, 1996
Degradation kinetics of DMP 777, an elastase inhibitorK S Raghavan, D B Gray, T H Scholz, et al.
Journal of Medicinal Chemistry|July 23, 1993
Sulfonylmethanesulfonamide inhibitors of carbonic anhydraseT H Scholz, J M Sondey, W C Randall, et al.
Journal of Medicinal Chemistry|February 1, 1990
Topically active carbonic anhydrase inhibitors. 3. Benzofuran- and indole-2-sulfonamidesS L Graham, J M Hoffman, P Gautheron, et al.
Journal of Medicinal Chemistry|September 29, 1995
Pseudodipeptide inhibitors of protein farnesyltransferaseS J deSolms, A A Deana, E A Giuliani, et al.
Journal of Medicinal Chemistry|October 1, 1991
Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamidesK L Shepard, S L Graham, R J Hudcosky, et al.
Journal of Medicinal Chemistry|July 3, 1998
N-Arylalkyl pseudopeptide inhibitors of farnesyltransferaseS J deSolms, E A Giuliani, S L Graham, et al.
Pageof 1